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Our understanding of how complex carbohydrates function during embryonic development is still very limited, primarily due to the large
number of glycosyltransferases now known to be involved in their synthesis. To overcome these limitations, we have taken advantage of the
zebrafish system to analyze the function of complex carbohydrates during development by down-regulating the expression of specific
glycosyltransferases. Herein, we report the identification of the zebrafish ortholog of mammalian β1,4-galactosyltransferase I, β4GalT1, and its
requirement for proper convergent extension movements during gastrulation. β4GalT1 is expressed in the oocyte and throughout the embryo
during the first 24 h of development. Knockdown of zebrafish β4GalT1 by two independent morpholino oligonucleotides results in embryos with
a truncated anterior–posterior axis, as well as elongated somites and moderate defects in the patterning of the head mesenchyme. Co-injection of
zebrafish β4GalT1 mRNA returns galactosyltransferase activity to control levels and rescues the defects produced by morpholino
oligonucleotides. In situ hybridizations of various molecular markers reveal that the axial mesoderm of epiboly stage embryos is abnormally
widened in β4GalT1 morphants, indicative of abnormal convergent extension. Consistent with this, the rate of anterior–posterior axis elongation
is reduced relative to control-injected embryos, similar to that seen in known convergent extension mutants. Among the many potential substrates
for β4GalT1 is laminin, a principle component of the extracellular matrix that supports cell movements such as those that occur during convergent
extension. Previous in vitro studies have shown that the galactosylation status of laminin directly influences its ability to support cell spreading
and migration. In this regard, laminin isolated from β4GalT1 morphant embryos is poorly galactosylated, which may contribute to defective cell
migration during convergent extension movements. This work demonstrates that zebrafish can be used to identify critical developmental roles for
specific glycosyltransferases that would not be obvious otherwise, such as an absolute requirement for β4GalT1 during convergent extension
movements.
© 2006 Elsevier Inc. All rights reserved.Keywords: Convergent-extension; Galactosyltransferase; ZebrafishIntroduction
Complex carbohydrates are predominant components of the
extracellular matrix and the cell surface where they participate in
a variety of cellular interactions (Varki, 1993). The enzymes that
are largely responsible for their synthesis are the glycosyltrans-
ferases, a highly polymorphic class of single pass, type II
transmembrane proteins that reside in the endoplasmic reticulum
and Golgi apparatus. Most glycosyltransferases catalyze the
addition of individual monosaccharides, donated from sugar⁎ Corresponding author. Fax: +1 404 727 6256.
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doi:10.1016/j.ydbio.2006.05.024nucleotide substrates, onto the growing polysaccharide chain
resulting in a specific glycosidic linkage. Surprisingly, it is now
known that most glycosidic linkages can be synthesized by a
multiplicity of distinct enzymes; for example, there are at least
six unique transcripts in mammalian tissues that encode
enzymes with β1,4-galactosyltransferase (β4GalT) activity.
Currently, it is thought that nearly 300 glycosyltransferases are
functional in mammalian tissues, but we know little about their
individual expression patterns or function in vivo, and our
understanding of their distinct substrate specificities is limited to
in vitro biochemical assays.
This high degree of polymorphism has made it difficult to
analyze glycosyltransferase function during mammalian
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suggesting that β4GalT is critical for proper cell migration both
in vitro and in vivo (Furukawa and Sato, 1999) embryonic
development appears largely unaffected in mice bearing targeted
mutations in β4GalT1 (Asano et al., 1997; Lu et al., 1997),
which may reflect the presence of other β4GalTs that
compensate for the loss of β4GalT1. Consequently, while
many investigators have suggested that glycosyltransferases are
essential for early vertebrate development, a system has yet to be
developed to test this possibility more exhaustively.
In an attempt to overcome the limitations inherent in mam-
malian systems, we have turned to the zebrafish system to
identify essential functions for individual glycosyltransferases
during vertebrate embryogenesis. Herein, we report the
identification and characterization of β4GalT1 from zebrafish
that is orthologous to mammalian β4GalT1 and β4GalT2.
Zebrafish β4GalT1 is expressed throughout the embryo during
the first 24 h of development, and knockdown of β4GalT1
results in embryos with a truncated anterior–posterior axis. The
axial domain is widened and the rate of anterior–posterior axis
elongation is reduced, illustrating a requirement of β4GalT1
during convergent extension movements. Furthermore, we
confirmed that knockdown of β4GalT1 leads to greatly reduced
galactosylation of extracellular glycoproteins, notably laminin,
that support cell migration in in vitro model systems. Since the
galactosylation status of laminin is known to influence its ability
to support cell migration, the reduced galactosylation of laminin
in β4GalT1 morphants may be one of the factors contributing to
defective convergent extension movements in these embryos.
Materials and methods
Staging and maintenance of zebrafish
All zebrafish were maintained as described previously (Westerfield, 1993).
Wild-type embryos were collected from *AB parents. Embryos used for
microinjection were collected from a mixed population of *AB and AAB
backgrounds. Embryos were staged according to previously described criteria
(Kimmel et al., 1995).
Identification and cloning of zebrafish β4GalT1 cDNA
A putative zebrafish β4GalT1 was identified through searches of the
zebrafish genome. Mouse and human sequences (accession #s: NM_022305,
NM_001497) were used as query for the search. Putative regions were selected
for RT-PCR directed cloning. 5′ and 3′ RACE techniques were used to clone
zebrafish β4GalT1, which produced three fragments corresponding to a 5′-
fragment, a central fragment and a 3′-fragment. Each fragment was used as a
probe for in situ hybridizations. Clone ID #7149167 (Open biosystems)
contained the first three exons encoding β4GalT1. Sequences corresponding to
mouse and human β4GalT2 transcripts (NM_017377, NM_003780) were used
to generate a phylogenetic tree. Sequences were aligned using CLUSTAL W,
and the phylogenetic tree was assembled using PHYLIP. Both programs were
provided by the Biology Workbench (SDSC).
In situ hybridizations
Whole-mount in situ hybridizations were performed as previously
described (Thisse and Thisse, 1998). Briefly, staged embryos were fixed
in 4% paraformaldehyde and dehydrated in methanol. Following rehydration
into PBS plus 0.1% Tween-20, embryos were prehybridized for 1 h at65°C. Hybridization with gene specific probes was performed overnight at
65°C. DIG-labeled probes were detected with anti-DIG antibodies (Roche)
and visualized with BCIP/NBT (Vector Labs). Plasmids containing chordin
(M. Halpern, Carnegie Institution of Washington, Baltimore, MD), cyclops
(I. Dawid, National Institutes of Health, Bethesda, MD), no tail (zfin EST
#cb240), her1 (J. Campos-Ortega, Universitat zu Koln, 50923 Koln,
Germany), were graciously provided. knypek (NM_131860), MyoD
(NM_131262) and PAPC (AF042191) were independently cloned using
published sequence information into pCRII (Invitrogen) and used to
generate RNA probes. β4GalT1 fragments were cloned into pCRII and
used to generate sense and anti-sense RNA probes. At least 10 embryos
were used in each assay. All in situ hybridizations were repeated at least
three times. Control hybridizations using sense strands were performed for
each probe to determine background signal.
Microinjection of morpholinos and mRNA
Antisense morpholino oligonucleotides were designed to compliment
either the start codon of β4GalT1 (5′-GAATCCCACCGACTCCGACATTC-
TC-3′) or an internal splice site of β4GalT1 (5′-ACTCGCAGTTGACCCAC-
TAAAAGTG-3′) (Gene-Tools). Morpholinos were resuspended in 1× Daneao
Buffer prior to injection (Nasevicius and Ekker, 2000). Various concentrations,
as indicated in the text, were injected into the cytoplasmic steam of 2- and 4-
cell embryos. Control embryos were injected with identical concentrations of
an irrelevant morpholino (5′-CCTCTTACCTCAGTTACAATTTATA-3′). Ma-
ture capped and poly-adenylated mRNAwas transcribed off BamH1 linearized
plasmids using the T7 or Sp6 mMessage mMachine kit (Ambion). mRNAwas
diluted in water, and various concentrations were injected into the cytoplasmic
stream of 2- and 4-cell embryos. Controls were injected with the same con-
centration of antisense mRNA.
Galactosyltransferase enzyme assay
Galactosyltransferase activity was assayed under optimal conditions as
previously described (Lu et al., 1997). Briefly, control and morpholino
injected embryos were collected at the 18 somite stage and dechorionated.
The yolk was removed using fine tungsten needles, and embryos were
immediately transferred into ice-cold Medium B (140 mM NaCl, 4 mM
KCl, and 20 mM HEPES [N-2-hydroxyethylperazine-N′-2-ethanesulfonic
acid], pH 7.2) and a cocktail of protease inhibitors (PIC; 2 mg/ml antipain,
0.1% aprotinin, 10 mg/ml benzamide, 1 mg/ml chymostatin, 1 mg/ml
leupeptin, and 1 mg/ml pepstatin). Embryos were rinsed four to five times,
2 min each, in Medium B/PIC and collected in 200 μl of Medium B/PIC.
Embryos were sonicated with two short pulses, 2 μl of Triton X-100 was
added, followed by one short pulse. The lysate was centrifuged to remove
any remaining particulate material, and the protein concentration of the
clarified lysate was determined using DC Protein Assay (BioRad). Aliquots
(∼9 μg protein) were incubated with 100 mM UDP[3H]Gal (NEN
Radiochemicals; 287 dpm/pmol), 1 mM 5′-AMP, 10 mM MnCl2, and
30 mM GlcNAc in a total volume of 50 μl and incubated at 37°C. At the
indicated time, assays were terminated by addition of 0.2 M EDTA, Tris–
HCl, pH 7.2 and aliquots were subjected to high-voltage borate
electrophoresis to separate the [3H]-labeled galactosylated products from
the unincorporated UDP[3H]Gal. The radiolabeled products remaining at the
origin were quantified by liquid scintillation counting.
Anterior–posterior axis quantification
The length of the anterior–posterior axis was determined as described
previously (Sepich et al., 2000). Prior to bud stage, the length of the
hypochord was determined by measuring the length of cyclops expression.
From bud stage to Prim-16 stage, the length of the anterior–posterior axis
was determined by averaging the length from the polster to the ventral tail
bud, and the length of the nasal placode to the dorsal tail bud, using NIH
Image to calculate the length in mm. To determine the width of the axial
domain, 80–90% epiboly stage embryos were subjected to in situ
hybridization of no tail, cyclops, papc and her1. The width of the axial
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widest and narrowest regions. This analysis was conducted with multiple
embryos for each marker as well as with multiple markers to ensure an
accurate measurement of the axis width and length. Knypek data were
adapted from (Topczewski et al., 2001).
Analysis of laminin galactosylation
Immunoprecipitation and lectin blotting were used to determine the
glycosylation state of laminin. Embryos injected with either control or
β4GalT1 morpholinos were allowed to develop until the 26-somite stage.
Embryos were dechorionated and lysed in ice-cold lectin extraction buffer
(0.5% w/v Triton X-100, 0.15 M NaCl, 10 mM EDTA, 20 mM Tris–HCl,
pH 7.4). The lysate was sheared with a 27-g needle and cleared of DNA
and lipids by chloroform–methanol extraction. Briefly, four volumes of
methanol were added to the lysate and mixed, followed by one volume of
chloroform, mixed, and three volumes of water, and mixed. The solution
was centrifuged at 9000 × g for 1 min, and the upper phase was discarded.
To the interphase and lower phase, three volumes of methanol were added,
mixed, and centrifuged at 9000 × g for 2 min. The protein pellet was dried
and resuspended in water. Protein concentration was determined using DC
Protein Assay (BioRad).
Anti-laminin antibodies (Sigma) were attached to Affi-gel beads
(BioRad). Beads were washed two times in 20 mM HEPES, pH 7.4.
Anti-laminin antibody was incubated with the beads for 1 h at room
temperature. Unbound sites on the beads were blocked with 2.5% 1 M
ethanolamine for 1 h at room temperature. The antibody-bound beads were
washed two times with 20 mM Tris–HCl, pH 7.4 and stored at 4°C until
used. Isolated embryo lysate was applied to the anti-laminin beads and
incubated for 24 h at 4°C. The beads were washed with 20 mM Tris–HCl,
pH 7.4 and resolved on 6% SDS-PAGE. The gel was transferred to a
PVDF membrane and blocked with oxidized BSA at 37°C for 1 h. The
membrane was blotted with 8 μg/ml RCA-I-AP (EY Labs) for 2 h at room
temperature. RCA reactivity was detected with BCIP/NBT. The membranes
were cleared by a brief wash in methanol.Results
Zebrafish β4GalT1 is homologous to the mammalian transcript
In order to identify zebrafish galactosyltransferases, the
mammalian β4GalT1 sequence was used to query the
zebrafish genomic database. One sequence was identified
that had high homology with the input sequence. The
identified sequence is predicted to be located on linkage
group 12 spanning approximately 34 kb and contain four
exons producing a transcript of 1086 bp. Translation of the
mRNA (Fig. 1A) predicts a polypeptide of 362 amino acids
containing the three amino acid motifs (DVD, FNRA and
WGWGEDDD) (boxed red in Fig. 1A) thought to be essential
for β4GalT catalytic activity. The sequence has 44% identity
to mammalian β4GalT1 and was therefore considered to be
the zebrafish ortholog of β4GalT1. Furthermore, genes that
flank human β4GalT1, such as Nfx1 in the 5′ direction, and
Smu1 in the 3′ direction, are predicted to flank zebrafish
β4GalT1 as well. Interestingly zebrafish β4GalT1 has 40%
identity to mammalian β4GalT2, suggesting that zebrafish
β4GalT1 is related to both mammalian transcripts. This
hypothesis is further supported by protein alignment and
phylogenetic relationships (Fig. 1B), which suggest that
zebrafish β4GalT1 is closely related to both mammalian
β4GalT1 and β4GalT2.β4GalT1 is maternally loaded and expressed throughout
development
The temporal expression of β4GalT1 was determined by
semi-quantitative RT-PCR using staged RNA libraries (Fig.
2A). High expression is found in oocytes, and expression is
maintained at similar levels through Prim-16 stage embryos.
The spatial expression pattern of β4GalT1 was determined by
in situ hybridization using a probe against the most divergent
(i.e., 5′ end) region of the transcript, thus minimizing any
overlap with other β4GalT family members. β4GalT1
expression is ubiquitous in 80% epiboly embryos (data not
shown). By the 2-somite stage (Fig. 2B), expression is still
widespread; however, high levels of expression are detected at
the midline (possibly due to increased mass). A similar pattern
of expression is observed in 12-somite and 18-somite stage
embryos (not shown). By the 20-somite stage, expression
remains high in the lateral mesoderm of the trunk, but
expression stops abruptly at the level of the midbrain
(asterisks, Fig. 2C). Moreover, expression is increased
(above that found throughout the embryo) in the developing
lens (arrowhead, Fig. 2C) as well as in the presumptive nasal
placode (arrow, Fig. 2C). In situ hybridizations with sense
probes targeting the same region of β4GalT1 as the anti-sense
probes showed no reactivity at any of the stages assayed,
confirming the specificity of the observed expression.
Knockdown of β4GalT1 results in a truncated
anterior–posterior axis
To define the function of β4GalT1 during embryonic
development, morpholino oligonucleotides (MO) were used to
knockdown its expression. Two different morpholino oligonu-
cleotides were employed, one targeted to the translation start
site, β4GalT1MO1, the other targeted to an internal splice
acceptor site, β4GalT1MO2. As discussed below, both morpho-
linos produced similar phenotypes.
The earliest phenotype observed following injection of
10 ng of β4GalT1MOs occurs at 80% epiboly, at which time
the embryonic tissue releases off of the deep yolk cells
resulting in a bubbling effect (illustrated by asterisk in Fig.
5E). The release of tissue may reflect reduced cell adhesion
to the underlying basement membrane. During early somi-
togenesis, the morphant phenotype is manifest as a lateral
elongation of the somitic mesoderm (arrowheads indicate
lateral termini, Fig. 3A) as well as an undulation of the
notochord (arrows, Fig. 3A). Moreover, morphant embryos
at this stage begin to exhibit a truncated anterior–posterior
axis.
By the time control-injected embryos have reached the
26-somite stage (Fig. 3B), embryos injected with β4GalT1-
MOs show defects associated with the head mesenchyme,
somite structure, and tail truncation and/or bending (Table 1).
Morpholino-injected embryos were classified according to
the severity (i.e., penetrance) of the morphant phenotype.
Class 1 morphants show the mildest phenotype, characterized
by a moderate disruption in the lateral head mesenchyme and
Fig. 1. β4GalT1 is a zebrafish ortholog of mammalian β4GalT1. β4GalT1 was identified by in silico homology to human β4GalT1 and was cloned from a 48 h total
RNA library. (A) Alignment of β4GalT1 from zebrafish (dr/red) human (h) and mouse (mm). Identical residues are shaded. Predicted catalytic residues are boxed in
red, and cysteines used to align the sequences are boxed in blue. (B) Unrooted phylogenetic tree demonstrating the relationship between zebrafish β4GalT1 (red) and
human (green) and mouse (blue) β4GalT1 and β4GalT2, suggesting an ancestral relationship.
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morphant embryos. The majority of the β4GalT1 morphants
(66–77%, Classes 2 and 3 combined) show severe truncation
and bending of the tail, as well as very narrow and elongated
somites, which likely contribute to the bending and
truncation observed in the tail (Fig. 3C). The most severe
of these (Class 3, ∼55%) have decreased overall head size,
and their trunk is significantly shorter, at times failing to bud
off the yolk.
Injection of either morpholino oligonucleotide resulted in
near identical phenotypes; however, the translation blocking
morpholino, β4GalT1MO1, produced a slightly higher pene-
trance (83% morphant phenotype) than that produced by the
splice blocking morpholino, β4GalT1MO2 (72%). This is most
likely due to the participation of maternal transcripts, since
morpholino oligonucleotides that inhibit splicing, such as
β4GalT1MO2, do not inhibit maternally supplied messages
(Draper et al., 2001).Three sets of control assays were performed to determine
whether the morphant phenotypes were due to knockdown of
β4GalT1. First, every experiment included ∼20 embryos that
were injected with equal amounts of an irrelevant morpholino,
such that over 500 control injections have been assayed thus
far. The degree of embryonic death was similar (<10% death)
in all injections, irrelevant of the morpholino injected. How-
ever, developmental defects were only seen in embryos
injected with β4GalT1-specific morpholinos; all surviving
embryos injected with control morpholinos appeared normal
(Fig. 3).
Second, we determined whether co-injection of full-length
zebrafish β4GalT1 mRNA could rescue the morphant pheno-
type produced by β4GalT1 morpholino oligonucleotides.
Embryos were co-injected with both β4GalT1MO2 and mature
mRNA transcribed from EST 714617, which encodes the first
three exons of β4GalT1 (Fig. 3D). After co-injection of mRNA
and β4GalT1MO2, the percentage of embryos with a wild-type
Fig. 2. β4GalT1 is expressed throughout the first 24 h of embryonic development. (A) Semi-quantitative RT-PCR for β4GalT1 in staged RNA libraries; oocyte, 50%
epiboly, 12-somite and Prim-16. Expression is first detected in the oocyte and remains relatively constant in all stages assayed. Error bars = ±SEM. (B, C) In situ
hybridizations for β4GalT1. (B) Two-somite stage, lateral and dorsal views, display β4GalT1 expression throughout the embryo. The increased signal in the midline
(arrow) is most likely due to increased tissue mass. (C) 26-somite stage embryos; lateral, dorsal at the midbrain level, and nasal views are shown, demonstrating tissue-
specific increases in expression. β4GalT1 expression in the lateral mesoderm ends abruptly at the midbrain level (asterisks) and shows high expression in the
developing retina (arrowhead) and nasal placode (arrow).
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β4GalT1 mRNA in the absence of morpholino oligonucleotide
failed to produce any noticeable phenotype.
Finally, we asked whether the morphant embryos showed
decreased levels of galactosyltransferase enzyme activity,
which would also demonstrate that the putative zebrafish
β4GalT1 sequence identified here, is in fact, an authentic
galactosyltransferase. However, an intrinsic difficulty with this
approach is that the substrate specificity of the putative zeb-
rafish β4GalT1 enzyme is not known, nor is it known for any
of the zebrafish β4GalT isoforms. Therefore, we relied upon
conditions developed for the mammalian enzyme in which
the free monosaccharide, N-acetylglucosamine (GlcNAc) is
used as the sugar acceptor substrate (Lu et al., 1997). Lysates
from control-injected embryos display abundant galactosyl-
transferase activity towards GlcNAc, whereas lysates from
β4GalT1 morphants produce ∼70% of control levels ofactivity (Fig. 4). A similar reduction in activity was seen in
three assays, two using β4GalT1MO1 (67% and 70% of
control activity) and one with β4GalT1MO2 (71% of control
activity).
Importantly, the ∼30% reduction in activity was seen in 18
somite stage embryos at which time the morphant phenotype
was relatively modest. Assays of embryos with very severe
phenotypes, resulting from either continued development to
the 26-somite stage, or from higher levels of injected
morpholino, were unreliable, possibly due to upregulation of
other β4GalT isoforms. Since morphant embryos with only
modest phenotypes were assayed, and the relative activities of
the various zebrafish β4GalT isoforms towards GlcNAc
remain unknown, the 30% reduction in galactosyltransferase
activity can not be taken as an indication of the relative level
of β4GalT1 to the total repertoire of zebrafish galactosyl-
transferases. Nevertheless, the loss of activity demonstrates
Fig. 3. Knockdown of β4GalT1 results in a complex patterning defect. (A) One-somite embryos injected with either control or β4GalT1 morpholino oligonucleotides.
In β4GalT1MO embryos, the notochord shows an undulating phenotype (doted lines) and extensively elongated somites (brackets). (B) 10-somite stage embryo
illustrating the laterally elongated somites (bracket). (C) 26-somite stage embryo injected with control morpholino oligonucleotides displays a wild-type phenotype.
(D) 26-somite stage β4GalT1MO embryos have a complex phenotype, consisting of a truncated anterior–posterior axis, disorganization of the lateral mesoderm, and
bending of the tail. (E) Embryos injected with β4GalT1MO2 and an EST encoding the putative catalytic domain of zebrafish β4GalT1 results in a “rescue” of the
morphant phenotype.
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galactose:N-acetylglucosamine βgalactosyltransferase. Finally,
galactosyltransferase activity returned to control levels inTable 1
Quantification of b4GalT1 morphant and mRNA rescue phenotype
Wild type Class 1 Class 2 Class 3 Total
displaying
phenotype
10 ng MO1
(n = 328 a)
17% (56 b) 6% (20) 20% (65) 57% (188) 83% (273)
10 ng MO2
(n = 229)
29% (63) 6% (15) 13% (29) 53% (122) 72% (166)
10 ng MO2 +
60 pg
drβ4GalT1
mRNA
(n = 31)
61% (19) 16% (5) 0 23% (7) 39% (12)
60 pg
drβ4GalT1
mRNA
(n = 26)
100% (26) 0 0 0 0
MO1 = translation blocker.
MO2 = splice blocker.
a Total embryos treated.
b Total embryos in each class.morphant embryos rescued by co-injection of the β4GalT1
mRNA.
Knockdown of β4GalT1 leads to defective convergent extension
movements
There are several key characteristics of the β4GalT1
knockdown phenotype, the most prominent being a truncation
of the anterior–posterior axis and lateral elongation of the
somitic mesoderm—hallmarks of defective convergence exten-
sion. In general, the β4GalT1 morphants phenocopy the
spectrum of phenotypes observed in zebrafish mutants known
to have defects in convergent extension, which include
silberblick (slb), pipetail (ppt), knypek (kny), trilobite (tri) and
strabismus (stb) (Heisenberg et al., 2000; Jessen et al., 2002;
Kilian et al., 2003; Sepich et al., 2000; Topczewski et al., 2001).
The more moderate mutants, such as slb, tri and stb, have an
undulating axis at early somitogenesis and a curved trunk at
later stages, similar to that seen in Class 1 and the milder Class 2
β4GalT1 morphants. More severe mutants, such as ppt and kny,
have a dramatic reduction in the anterior–posterior axis, as well
as laterally elongated somites, as do more severe Class 2 and the
Class 3 morphants. Since the phenotype we observed in
β4GalT1 morphant embryos is similar to mutants with defective
Fig. 4. Reduced galactosyltransferase activity in β4GalT1 morphant embryos.
Lysates of control-injected (•), morpholino-injected (○), and morpholino +
β4GalT1 mRNA injected (i.e., rescued) (◊) embryos were assayed for
galactosyltransferase activity towards N-acetylglucosamine (GlcNAc). A 30%
reduction in activity is seen in lysates from morphant embryos (moderate
phenotype at 18 somite stage), relative to lysates from control-injected embryos.
Results are representative of three independent assays (two MO1, one MO2).
Co-injection of mRNA encoding the catalytic domain of zebrafish β4GalT1
along with MO2 rescued the morphant phenotype (Fig. 3) and brought
galactosyltransferase activity back to control levels. The relative decrease in
activity (∼30%) should not be taken as an indication of the relative contribution
of β4GalT1 to the total repertoire of zebrafish galactosyltransferases, since
residual β4GalT1 transcripts likely remain and the relative affinity of the
different β4GalT isoforms towards GlcNAc is unknown.
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morphants display convergent extension defects using do-
main-specific markers.
Molecular markers confirm defective convergent extension in
β4GalT1 morphants
Initial in situ hybridizations were performed on 80–90%
epiboly stage embryos (Fig. 5). Wild-type embryos probed for
the axial marker no tail (ntl; Schulte-Merker et al., 1994) have
strong expression in the axis that appears as an elongated
narrow stripe; additional expression is detectable in cells of the
margin (Fig. 5A). Embryos injected with β4GalT1MO1 retain
ntl expression in the margin and the axis; however, the axial
region is significantly shorter and wider in the morphant
embryos (Fig. 5A). When wild-type embryos are probed with
cyclops (cyc; Hatta et al., 1991) to highlight the overlying axial
ectoderm, the expected narrow stripe along the floorplate of the
neural tube is observed (Fig. 5B). β4GalT1MO1 embryos retain
cyc staining; however, similar to that seen with ntl, the
expression domain is wider and slightly shorter than in wild-
type embryos (Fig. 5B).
To determine if the morphant phenotype is restricted to the
axis, in situ hybridizations were performed with markers of the
lateral mesoderm; paraxial protocadherin (PAPC) (Fig. 5C) and
hairy/enhancer-of-split-related 1 (her1) (Fig. 5D) (Takke and
Campos-Ortega, 1999; Yamamoto et al., 1998). In wild-type
embryos, both of these transcripts are expressed in the lateral
mesoderm and are restricted from the axis. Moreover, theinterface between the axis and the lateral mesoderm is smooth.
In β4GalT1MO embryos, both PAPC and her1 are expressed in
and restricted to the lateral mesoderm as in wild-type, and
highlight the wider axial domain in β4GalT1MO1morphants as
compared to control-injected embryos (bracket, Fig. 5C).
Furthermore, unlike that seen in wild-type embryos, the inter-
face between the axial and lateral mesoderm fields is irregular in
β4GalT1MO1 embryos.
As an independent means to assess convergent-extension
movements, the expression of kny was assayed (Fig. 5E). In
wild-type embryos, kny is expressed in the axis as well as in
the lateral mesoderm but is excluded from a domain
contralateral to the dorsal axis, called the evacuated zone
(brackets, Fig. 5E) (Topczewski et al., 2001). Cells in this
region have already converged into the axis, and therefore no
longer require kny expression. In contrast, embryos injected
with β4GalT1MO1 retain expression of kny in the presumptive
evacuated zone (Fig. 5E), consistent with a failure of these
cells to undergo convergent movements and thus continue to
express kny.
To determine if β4GalT1MO1 embryos follow a similar
developmental course as do known convergent extension
mutants, the expression of ntl, MyoD, her1 and EphA4 was
assayed in mid-somite stage embryos (Figs. 5F–J) (Weinberg
et al., 1996). Both wild-type and β4GalT1MO1 embryos
express ntl in the notochord (Fig. 5F), but the notochord has
an undulating appearance in β4GalT1 morphants, representa-
tive of defective convergent extension movements. Another
characteristic of convergent extension mutants, such as seen in
frizzled-2 morphant embryos, is severely reduced expression
of MyoD in the somitic mesoderm, but continued high ex-
pression of MyoD in the adaxial cells that flank the notochord
(Sumanas et al., 2001). β4GalT1 morphant embryos show a
similar pattern of MyoD expression, in that it is nearly absent
in the somitic mesoderm, but expression appears normal in the
adaxial cells (arrowheads, Fig. 5G). Finally, the specification
of the lateral mesoderm and central nervous system appears
relatively normal, as determined by expression of her1 (Fig.
5H) and EphA4 (Figs. 5I, J), respectively. It is interesting,
however, that her1 expression is more diffuse in the somitic
mesoderm than in control embryos, which may indicate a role
for β4GalT1 in Notch-dependent signaling, as has been
suggested in mammalian tissues (Chen et al., 2006). However,
the β4GalT1 morphants do not show the characteristic defects
seen in frizzled-2 mutants, such as broader somites (as apposed
to more elongated somites in convergent extension mutants)
and retained MyoD expression in the somitic mesoderm
(Henry et al., 2002). Consequently, these data suggest that
although β4GalT1 likely participates in other developmental
pathways, such as Notch signaling, the dominant defect seen
in β4GalT1 morphants appears to be defective convergent
extension.
Analysis of the anterior–posterior axis in β4GalT1 morphants
The in situ hybridizations show that the axial domain of
β4GalT1 morphant embryos is significantly wider than in wild-
Fig. 5. Molecular markers define an early axial patterning defect in β4GalT1 morphant embryos. (A–E) Control and β4GalT1MO embryos at 80–90% epiboly. (F–J)
Control and β4GalT1MO embryos at the mid-somite stage. In situ hybridization for ntl (A) and cyc (B) shows shortened and widened expression domains in
β4GalT1MO embryos. (C) In situ hybridization for PAPC marks the lateral mesoderm, illustrating a wider and more irregular axial domain (bracket) than in control
embryos. (D) her1 in situ hybridizations reveal that fgf signaling is occurring in the lateral mesoderm, but the axial mesoderm interface is irregular, as seen with PAPC.
(E) kny expression is retained in the evacuated zone (bracket indicates the evacuated zone) suggesting a defect in convergent extension. (F) ntl expression continues to
be truncated in 10-somite β4GalT1MO embryos, and shows severe undulation. (G) MyoD expression is retained in the adaxial cells (arrowheads) of β4GalT1MO
embryos, whereas expression in the somitic mesoderm is markedly reduced relative to control embryos. (H–J) Patterning of the somitic mesoderm and central nervous
system appear relatively normal in β4GalT1MO embryos as indicated by her1 (H) and EphA4 (I, J) expression, respectively, although the somitic mesoderm is more
diffuse and the notochord retains its undulating appearance, as seen with ntl.
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hybridizations of ntl, cyc, and PAPC, and calculated as the
average of the narrowest and widest widths (Fig. 6A). The
average width of the axial domain in control-injected embryos is
uniform among embryos and was set to a relative value of 1.
Embryos injected with β4GalT1MO1 have more variable axial
widths, and average 63% wider than wild type.
The increased axial domain in morphant embryos is
consistent with defective convergent extension movements.
This was supported by comparing the rates of axis elongation
in control and morphant embryos (Fig. 6B). Two major
elongation events are observed in control-injected embryos(♦, Fig. 6B), one during epiboly (8–12 h p.f.) and one during
mid-somitogenesis (18–26 h p.f.), which are separated by a
period of minimal elongation during early somitogenesis (14–
18 h p.f.). Embryos injected with β4GalT1MO1 (▪, Fig. 6B)
undergo initial axis elongation at a rate similar to wild-type
controls, although the axis is shorter. However, β4GalT1MO1
embryos are unable to undergo the second elongation event,
and thus, these embryos have a significantly shorter anterior–
posterior axis than control embryos. Interestingly, the rate of
anterior–posterior axis elongation in known convergent
extension mutants, such as kny (▴, Fig. 6B), is similar to
that seen in β4GalT1 morphants reported here, particularly
Fig. 6. Quantification of abnormal anterior–posterior axis morphology in
β4GalT1MO embryos. (A) The width of the dorsal axis was determined at 85%
epiboly for both control and β4GalT1MO embryos. The axial width in control
embryos was set to 1. The axial width in β4GalT1MO embryos is increased by
63%. Error bars = ±SEM. (B) The rate of anterior–posterior axis elongation was
determined for both control and β4GalT1MO embryos. Control embryos (♦)
undergo a sharp elongation between 8 and 12 h post-fertilization that is also seen
in β4GalT1MO embryos (▪); however, the β4GalT1MO embryos are slightly
shorter. Following 14 h of development, control embryos undergo a second
elongation event, which is absent in β4GalT1MO embryos. These results mimic
those reported for classic convergent extension mutations, such as kny (▴)
(adapted from Topczewski et al., 2001).
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stages and a dramatically reduced elongation rate during later
stages of somitogenesis (Sepich et al., 2000; Topczewski et
al., 2001).
Laminin is improperly galactosylated in β4GalT1 morphant
embryos
In mammalian tissues, β4GalT1 galactosylates a wide
range of glycoprotein substrates. It is therefore likely that
knockdown of zebrafish β4GalT1 results in reduced galacto-
sylation of multiple substrates, any one of which may
contribute to the defective convergent extension seen in
β4GalT1 morphants. Nevertheless, since convergent exten-
sion requires extensive cellular migration along the basement
membrane, we felt it important to determine whether
glycoproteins known to support cell migration in in vitro
model systems show reduced galactosylation in β4GalT1
morphants. Laminin was chosen as an appropriate candidate
for this analysis, since it has been shown that laminin's ability
to support cell migration is dependent, at least in part, on itsgalactosylation status (Runyan et al., 1988; Tanzer et al.,
1993).
Embryos were injected with either control or β4GalT1
morpholino oligonucleotides and allowed to develop for 24 h.
Embryos were lysed and laminin was immunoprecipitated as
described. The precipitated material was resolved by SDS-
PAGE, transferred to PVDF membranes and assayed for the
presence of β4Gal residues using RCA-I lectin (Fig. 7A).
Two major RCA-reactive bands, at 400 kDa and 200 kDa,
were evident in laminin immunoprecipitated from control
embryos. Immunoblotting with anti-laminin antibodies con-
firmed that the 200-kDa band corresponds to the β and γ
chains of laminin, whereas the 400-kDa band represents the α
chain. All RCA-reactive bands were inhibited by 0.5 M
galactose, demonstrating the appropriate lectin specificity for
galactose (data not shown). In contrast, laminin from
β4GalT1MO-injected embryos retained only a faint RCA-
reactive band at 400 kDa and even less RCA reactivity in the
200-kDa region, indicating that the laminin subunits are
dramatically under-galactosylated. Immunocytochemistry
illustrates that laminin is properly localized along the
notochord in both control and β4GalT1 morphant embryos,
suggesting that reduced galactosylation of laminin does not
alter its general localization (Fig. 7B). It was somewhat
surprising that the under-galactosylated laminin from
β4GalT1 morphants resolved at similar molecular weights
to laminin from control embryos, suggesting that any
reduction in molecular weight due to the β4GalT1 deficiency
is too small to be resolved by the 6% SDS-polyacrylamide
gel. Nevertheless, the loss of β1,4-galactosyl residues on
laminin subunits is consistent with previous studies that
illustrate a role for laminin glycoside chains in cell migration
(Evans et al., 1995) and may be a contributing factor in the
defective convergent extension movements seen in β4GalT1
morphant embryos.
Discussion
Attempts to decipher the function of complex carbohy-
drates during mammalian development using homologous
recombination have met with mixed success. Eliminating
enzymes required for the initiation of entire classes of
oligosaccharide chains, or those involved in sugar-nucleotide
synthesis, confirms that complex carbohydrates are indeed
essential for embryonic development (Ioffe and Stanley,
1994). However, of those studied thus far, elimination of
individual fucosyltransferase or galactosyltransferase tran-
scripts does not grossly alter embryogenesis (Domino et al.,
2001; Lu et al., 1997; Maly et al., 1996), which likely reflects
the redundancy now known to exist among these enzymes.
Thus, in order to efficiently analyze glycosyltransferase
function during development, an experimental system is
required that is more amenable to “high-throughput” assays.
The zebrafish system has enabled us to identify and
knockdown the expression of β4GalT1, thus uncovering a
novel and unexpected requirement in convergent extension
movements. The phenotype of the β4GalT1 zebrafish
Fig. 7. Laminin is improperly galactosylated in β4GalT1 morphant embryos.
(A) Control and β4GalT1MO embryos were lysed, and laminin was immuno-
precipitated with a-laminin antibodies. The immunoprecipitate was resolved by
SDS-PAGE and probed for RCA-I reactivity. Control embryos have strong
RCA reactivity at 400 kDa reflecting the α chain of laminin, as well as at
200 kDa, representing the β and γ chains. β4GalT1MO embryos retain only
weak RCA reactivity to the 400-kDa protein and almost no RCA reactivity at
200 kDa. (B) To confirm that β4GalT1MO embryos still express laminin,
control-injected and β4GalT1-morpholino-injected embryos were stained for
laminin. Control embryos (6 somites) have laminin expression along the
notochord as well as along the lateral mesoderm of the head. β4GalT1MO
embryos (12 somites) retain laminin expression along the notochord, although
the domain is wider.
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analysis of the mammalian β4GalT1 knockout phenotype.
Zebrafish β4GalT1 and human β4GalT1 are 44% identical
and share many features in common, including all of the peptide
sequences believed to be essential for catalytic activity. Both
genes contain five exons and span a similar distance in the
genome. Much of the genome surrounding zebrafish β4GalT1 is
incompletely annotated, making it difficult to determine if
similar genes flank both zebrafish β4GalT1 and human
β4GalT1; however, there is evidence to suggest that genes
immediately flanking human β4GalT1, such as Nfx1 and Smu1,
also flank zebrafish β4GalT1. It is interesting that the only
mammalian β4GalT family member without a clear zebrafish
ortholog is β4GalT2 (data not shown). Sequence analysis of the
zebrafish β4GalT family suggests that β4GalT1 may be
ancestral to both β4GalT1 and β4GalT2, raising the possibility
that the functions of zebrafish β4GalT1 may be distributed
between the two human enzymes.
β4GalT1 shows widespread expression throughout the
zebrafish embryo, which is not surprising as glycosyltrans-
ferases are required for the post-translational modification of
all membrane-bound and secreted glycoconjugates. Further-
more, work by others has shown that β4GalT1 is the most
widely expressed β4GalT1 in mammalian fetal and adult
tissue (Lo et al., 1998), and that its expression is highest in
mesenchymal tissue and lowest in brain (Sato et al., 1998).
This is similar to the high levels of β4GalT1 expression inzebrafish embryonic mesenchyme reported here. The strong
β4GalT1 expression in the lens and nasal placode of 20-
somite embryos also suggests that it may play a role in the
development of either, or both, of these organs.
In order to characterize the defects resulting from knock-
down of β4GalT1 in zebrafish, we compared the morphant
phenotype with known zebrafish mutants. One class of mutants
in particular, those that affect convergent extension movements,
have characteristics similar to those reported here for β4GalT1
morphant embryos. Convergent extension is a process that
relies on coordinated cell movements to both elongate and
narrow a field of cells. During vertebrate development, con-
vergent extension is employed primarily to elongate the
anterior–posterior axis. During invertebrate development, an
analogous pathway, called the planar cell polarity (PCP)
pathway, is used to establish eye and body bristle polarity
(Fanto and McNeill, 2004). Despite the extensive morpholog-
ical characterization of convergent extension movements, the
underlying molecular mechanisms are poorly understood.
However, recent studies of Drosophila and zebrafish mutants
have begun to decipher the mechanisms controlling convergent
extension and PCP.
Evidence suggests that convergent extension movements are
modulated by non-canonical wnt signaling; mutants in zebrafish
wnt5b (pipetail/ppt) or wnt11 (silberblick/slb), the dominant
non-canonical wnt proteins in vertebrates (Huelsken and
Behrens, 2002), leads to reduced anterior–posterior axes and
elongated somites, similar to the known convergent extension
mutants knypek (kny), trilobite (tri) and strabismus (stb) (Gong
et al., 2004; Heisenberg et al., 2000; Jessen et al., 2002; Kilian
et al., 2003; Sepich et al., 2000; Topczewski et al., 2001). One
of the most severe convergent extension mutants is kny, which
encodes a glypican, a highly glycosylated membrane-anchored
protein that modulates wnt11 signaling. Initially, kny is
expressed throughout the embryo, but following convergent
extension, expression of kny is excluded from the evacuated
zone, contralateral to the dorsal axis. Embryos injected with
β4GalT1MOs retain kny expression in the evacuated zone,
suggesting that cells in β4GalT1 morphant embryos are unable
to migrate and complete convergent extension.
Another critical link between the β4GalT1 morphant
phenotype and classic convergent extension mutants is the
stage-specific reduction in the rate of anterior–posterior axis
elongation. During epiboly and early somitogenesis, both kny
and tri mutants show normal rates of anterior–posterior axis
elongation, much as β4GalT1 morphants do. However, later in
somitogenesis, the rate of anterior–posterior axis elongation is
severely reduced in kny and tri mutants, as it is in β4GalT1
morphants (Sepich et al., 2000; Topczewski et al., 2001). All of
the data presented here indicate that at least one of the primary
defects in β4GalT1 morphants is defective convergent
extension movements. This does not eliminate the likely
possibility that β4GalT1 participates in other developmental
pathways during zebrafish embryogenesis, such as Notch, only
that convergent extension is the first to be identified.
Based upon previous in vitro studies of β4GalT1 function,
we favor the hypothesis that β4GalT1 functions during
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residues that are required for proper cell adhesion and/or
migration. Laminin, in particular, was selected for further
analysis, since it is a principle component of the basement
membrane upon which convergent extension movements
occur. Importantly, the carbohydrate chains on laminin have
been shown to be essential for at least some of its biological
activities (Tanzer et al., 1993), and of particular relevance to
this study, laminin's ability to support cell migration and
neurite outgrowth have been shown to be modulated by
interactions with β4GalT1 (Begovac et al., 1991). It is of
interest, therefore, that laminin is grossly under-galactosylated
in β4GalT1 morphant embryos, which may contribute to the
defective convergent extension movements seen in β4GalT1
morphant embryos. A direct test of this possibility awaits the
ability to isolate sufficient amounts of laminin from control
and β4GalT1 morphants to compare their ability to support
migration of zebrafish ectodermal cells and/or the ability of
laminin isolated form control embryos to rescue the
convergent extension phenotype in β4GalT1 morphants.
There are two known laminin mutants in zebrafish; one
mutation is in the γ chain, grumpy, and the other is in theβ chain,
sleepy (Parsons et al., 2002). However, neither of these mutants
have classical defects in convergent extension. This lack of an
effect on convergent extension may simply reflect the ability of
one of the other β or γ isoforms to compensate for the loss of
grumpy or sleepy. In contrast, the endogenous laminin
polypeptide chains are present in β4GalT1 morphants, but are
improperly galactosylated, which would inhibit their ability to
support cell adhesion and/or migration. In any event, it is
important to emphasize that although the defective convergent
extension movements seen in β4GalT1 morphants correlates
well with the appearance of under-galactosylated laminin, a
causative relationship awaits more direct testing.
In summary, we report here the identification and characteri-
zation of a β1,4-galactosyltransferase in zebrafish that has an
unexpected function during convergent extension. Knockdown
of β4GalT1 results in abnormal axial morphology, as well as a
reduced rate of anterior–posterior axis elongation that is similar
to classic convergent extension mutants. Furthermore, knock-
down of β4GalT1 leads to greatly reduced galactosylation of
laminin, the galactosylation status of which is known to
influence cell migration and which may contribute, along with
other putative β4GalT1 substrates, to the defect in convergent
extension.
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